Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Sales | 6,732 | 5,680 | 5,399 | 3,231 | 2,505 |
| Gross Profit | 6,732 | 5,680 | 5,399 | 3,231 | 2,505 |
| Operating Expenses | 48,203 | 46,506 | 59,444 | 66,539 | 79,003 |
| Operating Income | -41,471 | -40,826 | -54,045 | -63,308 | -76,498 |
| Interest Expense | 3,516 | 3,513 | 3,512 | 3,511 | 3,512 |
| Other Income | 522 | 485 | 448 | 565 | 659 |
| Pre-tax Income | -44,465 | -43,854 | -57,109 | -66,254 | -79,351 |
| Net Income Continuous | -44,465 | -43,854 | -57,109 | -66,254 | -79,351 |
| Net Income | $-44,465 | $-43,854 | $-57,109 | $-66,254 | $-79,351 |
| EPS Basic Total Ops | -3.20 | -3.20 | -4.20 | -4.80 | -5.80 |
| EPS Basic Continuous Ops | -3.14 | -3.20 | -4.21 | -4.89 | -5.86 |
| EPS Diluted Total Ops | -3.20 | -3.20 | -4.20 | -4.80 | -5.80 |
| EPS Diluted Continuous Ops | -3.14 | -3.20 | -4.21 | -4.89 | -5.86 |
| EBITDA(a) | $-39,059 | $-38,359 | $-51,471 | $-60,731 | $-74,176 |